✦ LIBER ✦

The effects of LY2189265, a long-acting glucagon-like peptide-1 analogue, in a randomized, placebo-controlled, double-blind study of overweight/obese patients with type 2 diabetes: the EGO study

✍ Scribed by G. E. Umpierrez; T. Blevins; J. Rosenstock; C. Cheng; J. H. Anderson; E. J. Bastyr III; for the EGO Study Group

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A 5-week study of the pharmacokinetics a

✍ P. Barrington; J. Y. Chien; H. D. H. Showalter; K. Schneck; S. Cui; F. Tibaldi; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 647 KB

Clinical trial: the glucagon-like peptid

✍ P. M. HELLSTRÖM; J. HEIN; P. BYTZER; E. BJÖRNSSÖN; J. KRISTENSEN; H. SCHAMBYE 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB

Efficacy and safety of alogliptin added

✍ K. Kaku; T. Itayasu; S. Hiroi; M. Hirayama; Y. Seino 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 564 KB

Addition of pioglitazone to stable insul

✍ J. A. Davidson; A. Perez; J. Zhang; The Pioglitazone 343 Study Group 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

Patient-reported outcomes following trea

✍ B. W. Bode; M. A. Testa; M. Magwire; P. M. Hale; M. Hammer; L. Blonde; A. Garber 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 556 KB

Efficacy and safety of the dipeptidyl pe

✍ M. A. Nauck; G. Meininger; D. Sheng; L. Terranella; P. P. Stein; Sitagliptin Stu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB